The Valley Desk

Clinical trial reportJCO precision oncologyPublished

Cobimetinib + Vemurafenib in Patients With BRAF V600E-Mutant Papillary Thyroid and Biliary Tract Cancers: Results From the TAPUR Study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
JCO precision oncology
Published
Subject terms
Humans; Biliary Tract Neoplasms; Thyroid Neoplasms; Azetidines; Piperidines; Proto-Oncogene Proteins B-raf; Antineoplastic Combined Chemotherapy Protocols; Mutation; Adult; Aged; Middle Aged; Female
PubMed ID
42886887
Added to directory
Source checked

Report a correction or request removal